CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | Mesa Nilda Director | Sale | −98 | $505.98 | $50K | 5,580 |
| 2026-09-14 | Mesa Nilda Director | Option exercise · Stock Option | −130 | 6,430 | ||
| 2026-09-14 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,580 | $502.15 | $793K | 332,363 |
| 2026-09-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,358 | $503.44 | $1.2M | 330,005 |
| 2026-09-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,722 | $504.47 | $1.4M | 327,283 |
| 2026-09-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,400 | $505.25 | $1.2M | 324,883 |
| 2026-09-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $506.48 | $223K | 324,443 |
| 2026-09-14 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 442,410 | ||
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,341 | $496.74 | $666K | 332,602 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,138 | $497.99 | $1.1M | 330,464 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,021 | $498.97 | $509K | 329,443 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −204 | $499.61 | $102K | 329,239 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −476 | $500.86 | $238K | 328,763 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,560 | $502.13 | $783K | 327,203 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −850 | $503.10 | $428K | 326,353 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −710 | $503.99 | $358K | 325,643 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −82 | $504.97 | $41K | 325,561 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −518 | $506.44 | $262K | 325,043 |
Page 37 of 121 · 2,404 trades